(CHF) Audited annual report as of 31 October 2019 Table of contents Organization Notices to investors Report of the independent auditor UBS (CH) Equity Fund – Asia (USD) Page 3 5 13 15 UBS (CH) Equity Fund – Emerging Asia (USD) 22 UBS (CH) Equity Fund – European Opportunity (EUR...
There were some exceptional performances in the thematic holdings, withRA Capital International Healthcaregaining 42.7%. The fund has seen several of its portfolio companies being acquired over the last six months. Icosavax was acquired by AstraZeneca at slightly above the IPO price, representing a...
CEO of Astra Zeneca Pascal Soriot speaks at a panel discussion themed on "The Health Equity Frontier - Closing the Rare Disease Care Gap" during the Boao Forum for Asia (BFA) Annual Conference 2024 in Boao, south China's Hainan Province, March 28, 2024. (Xinhua/Yang Guanyu) Executive Chai...
UBS (Lux) Equity Fund Annual Report as of 30 November 2012 5 "hedged" For unit classes whose reference currencies are not the same as those of the subfund, and which have "hedged" in their name ("unit classes in foreign currencies"), the fluctuation risk of the reference currency price...
2022 Remuneration policy summary 2022 Remuneration policy report 120 125 143 144 GSK Annual Report 2021 119 Remuneration report Committee Chair's annual statement Dear Shareholder, On behalf of the Remuneration Committee (the Committee), I am pleased to present our Remuneration report for 2021....
A recent report has demonstrated that a 1-year coefficient of variation of eGFR (CVeGFR) is associated with developing end-stage kidney disease for patients with chronic kidney disease16. However, whether CVeGFR is associated with developing end-stage kidney disease in the general population at ...
Committee Chair's annual statement Annual report on remuneration 2022 Remuneration policy summary 133 136 158 132 GSK Annual Report 2022 Remuneration report Committee Chair's annual statement Dear Shareholder, On behalf of the Remuneration Committee, I am pleased to present our Remuneration report for ...
欧洲药监局2021年度报告EMA :2021-annual-report-european-medicines-agency_en.pdf,ANNUAL REPORT 2021 The European Medicines Agency’s contribution to science, medicines and health in 2021 An agency of the European Union All photographs are copyright protec
This Annual Meeting 2023 Proceedings Report is protected by copyright law and international treaties. Unauthorized reproduction, distribution, or modification of this work, whether in whole or in part, is strictly prohibited. Any unauthorized use may result in severe civil and criminal penalties. The...
and cellular and immune responses to virus infection, and reinforce the position of viruses as uniquely powerful probes of cellular function.The Annual Review of Virology debuted in the 2016 Release of the Journal Citation Report (JCR) with an Impact Factor of 3.345.Join the conversation about thi...